The ways we advertise, patent and pay for drugs like the EpiPen hurt the sick
Cleveland Clinic News Service | 216.444.0141
We’re available to shoot custom interviews & b-roll for media outlets upon request.
CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.
images: 0
video: 0
audio: 0
text: 0
It’s become a familiar dance: A drug company buys a well-established medication developed by another company. It raises the price by an obscene amount. The public reacts with outrage. Congress proclaims the need for inquiries . . . And nothing changes. In a few months, we’re likely to go through all of this again, with another company and another drug—unless Congress tackles the issue with legislation, not just rhetoric, Cleveland Clinic’s Chief Pharmacy Officer Scott Knoer writes in TIME.
Read the entire piece at TIME.com: How to Stop Immoral Drug Price Increases
